CASE REPORT
|
doi:10.20944/preprints202312.2077.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Peritoneum, Mesothelioma, Cancer, Surgery
Online: 27 December 2023 (09:27:08 CET)
REVIEW
|
doi:10.20944/preprints202311.1174.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
malignant pleural mesothelioma; immunotherapy; biomarkers
Online: 17 November 2023 (14:27:32 CET)
REVIEW
|
doi:10.20944/preprints202207.0400.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
asbestos; chrysotile; mesothelioma; lung cancer
Online: 26 July 2022 (09:43:02 CEST)
ARTICLE
|
doi:10.20944/preprints202403.1058.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Mesothelioma patient-derived organoids, PDO, IL-6, mesothelioma-associated fibroblasts; cocultures, cisplatin; pemetrexed; chemoresistance
Online: 18 March 2024 (15:17:01 CET)
ARTICLE
|
doi:10.20944/preprints201908.0061.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
mesothelioma; predictive modeling; decision support system; early diagnosis
Online: 5 August 2019 (11:57:51 CEST)
REVIEW
|
doi:10.20944/preprints202401.0463.v1
Subject:
Medicine And Pharmacology,
Surgery
Keywords:
pleural recurrences; HITHOC; Mesothelioma; thymoma; robotic Surgery; thoracic neoplasms
Online: 5 January 2024 (07:04:23 CET)
ARTICLE
|
doi:10.20944/preprints202309.1347.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
pleural mesothelioma; mesothelial hyperplasia; pleural effusions; subtyping; gene expression
Online: 20 September 2023 (04:42:15 CEST)
ARTICLE
|
doi:10.20944/preprints202009.0380.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
malignant pleural mesothelioma; CXCL12/CXCR4; EAAT1; glutamine synthetase; invasion; migraiton
Online: 17 September 2020 (07:29:16 CEST)
ARTICLE
|
doi:10.20944/preprints201911.0117.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
malignant mesothelioma; epidemiology; association rule mining; Apriori method; imbalanced dataset
Online: 10 November 2019 (16:15:14 CET)
REVIEW
|
doi:10.20944/preprints202311.0331.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
pleural mesothelioma; treatable traits; novel therapeutic insight; CAR T cells therapy
Online: 7 November 2023 (02:31:14 CET)
ARTICLE
|
doi:10.20944/preprints202209.0285.v1
Subject:
Biology And Life Sciences,
Cell And Developmental Biology
Keywords:
mesothelioma; chick embryo; CAM; xenograft; bioluminescence; fluorescence; histology; MRI; preclinical; 3Rs
Online: 20 September 2022 (02:48:17 CEST)
ARTICLE
|
doi:10.20944/preprints202305.1698.v1
Subject:
Biology And Life Sciences,
Life Sciences
Keywords:
Cancer; Aggressiveness; Mitochondria; Acadvl; Fatty acid beta oxidation; Biomarker; Proteomics; Malignant mesothelioma
Online: 24 May 2023 (05:06:41 CEST)
ARTICLE
|
doi:10.20944/preprints202306.2242.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
malignant pleural mesothelioma; oxidative stress; redox-sensitive factors; asbestos; epithelial mesenchymal transition; proliferation
Online: 30 June 2023 (14:41:47 CEST)
ARTICLE
|
doi:10.20944/preprints202309.2118.v1
Subject:
Medicine And Pharmacology,
Surgery
Keywords:
cytoreductive surgery; extreme cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; malign peritoneal mesothelioma; peritoneal cancer index.
Online: 29 September 2023 (14:56:58 CEST)
ARTICLE
|
doi:10.20944/preprints202305.0978.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
malignant mesothelioma; metabolism; mitochondria; long-chain specific acyl-CoA dehydrogenase; fatty acid β-oxidation, biomarker
Online: 15 May 2023 (05:27:55 CEST)
REVIEW
|
doi:10.20944/preprints202402.1049.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
malignant pleural mesothelioma; immune checkpoint inhibitor; orphan drug; good clinical practice; Pharmaceuticals and Medical Devices Agency
Online: 20 February 2024 (04:03:22 CET)
ARTICLE
|
doi:10.20944/preprints202308.0382.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
pleural mesothelioma; subtypes; immunohistochemistry; Mesothelin; Claudin-15; Complement Factor B (CFB); Plasminogen Activator Inhibitor 1 (PAI1); p21-activated kinase 4 (PAK4).
Online: 4 August 2023 (12:34:31 CEST)